Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop
- PMID: 17974553
- DOI: 10.1093/annonc/mdm500
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop
Abstract
A subset of survivors has cognitive impairment after cancer treatment. This is generally subtle, but may be sustained. In October 2006, the second international cognitive workshop was held in Venice. The workshop included neuropsychologists, clinical and experimental psychologists, medical oncologists, imaging experts, and patient advocates. The main developments since the first Cognitive Workshop in 2003 have been the following. (i) studies evaluating cognitive function in patients receiving chemotherapy for cancers other than breast cancer, and in patients receiving hormonal therapy for cancer. (ii) The publication of longitudinal prospective studies which have shown that some patients already exhibit cognitive impairment on neuropsychological testing before receiving chemotherapy, and some patients have deterioration in cognitive functioning from pre- to postchemotherapy. (iii) Studies of the underlying mechanisms of cognitive impairment both in patients and in animal models. (iv) Use of structural and functional imaging techniques to study changes in brain morphology and activation patterns associated with chemotherapy. (v) At present cognitive research in cancer is limited by methodological challenges and the lack of standardization in neuropsychological studies. The current workshop addressed many of these issues and established an international task force to provide guidelines for future research and information on how best to manage these symptoms.
Similar articles
-
Cognitive impairment associated with chemotherapy for cancer: report of a workshop.J Clin Oncol. 2004 Jun 1;22(11):2233-9. doi: 10.1200/JCO.2004.08.094. J Clin Oncol. 2004. PMID: 15169812 Review.
-
Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research.Cancer Treat Rev. 2018 Sep;69:72-83. doi: 10.1016/j.ctrv.2018.05.017. Epub 2018 Jun 1. Cancer Treat Rev. 2018. PMID: 29909223 Review.
-
Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.J Clin Oncol. 2007 Jun 10;25(17):2455-63. doi: 10.1200/JCO.2006.08.1604. Epub 2007 May 7. J Clin Oncol. 2007. PMID: 17485710 Review.
-
New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors.J Pain Symptom Manage. 2013 Nov;46(5):707-21. doi: 10.1016/j.jpainsymman.2012.11.005. Epub 2013 Mar 21. J Pain Symptom Manage. 2013. PMID: 23522517
-
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.Lancet Oncol. 2011 Jul;12(7):703-8. doi: 10.1016/S1470-2045(10)70294-1. Epub 2011 Feb 25. Lancet Oncol. 2011. PMID: 21354373
Cited by
-
Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis.J Neurooncol. 2016 Aug;129(1):123-30. doi: 10.1007/s11060-016-2152-7. Epub 2016 May 30. J Neurooncol. 2016. PMID: 27241133
-
3D surface analysis of hippocampal microvasculature in the irradiated brain.Environ Mol Mutagen. 2016 Jun;57(5):341-9. doi: 10.1002/em.22015. Epub 2016 May 13. Environ Mol Mutagen. 2016. PMID: 27175611 Free PMC article.
-
Brain vulnerability to chemotherapy toxicities.Psychooncology. 2012 Nov;21(11):1141-8. doi: 10.1002/pon.3196. Epub 2012 Oct 1. Psychooncology. 2012. PMID: 23023994 Free PMC article. Review.
-
Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.J Clin Oncol. 2011 Jun 10;29(17):2397-404. doi: 10.1200/JCO.2010.33.9119. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537032 Free PMC article.
-
PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth.Oxid Med Cell Longev. 2016;2016:9392404. doi: 10.1155/2016/9392404. Epub 2015 Nov 10. Oxid Med Cell Longev. 2016. PMID: 26640619 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources